Lenoss Medical raised $4 million in a Series A financing to advance the OsteoPearl biological allograft implant
Lenoss Medical raised $4 million in a Series A financing to advance the OsteoPearl biological allograft implant
05/09/24, 9:13 PM
Location
providenceMoney raised
$4 million
Industry
health care
Round Type
series a
Investors
Angel Investment Groups, Right Hill Ventures, Vodia Capital, Highpoint Ventures, Xcellerant Ventures
Lenoss Medical, a pioneering medical device company, successfully closed an oversubscribed Series A funding round, gathering support from Xcellerant Ventures, Highpoint Ventures, Vodia Capital, RightHill Ventures, and various Angel Investment Groups. The funding will be used to accelerate commercialization, expand clinical evidence, and fuel innovative product development for the OsteoPearl implant.
Company Info
Location
providence, rhode island, united states
Additional Info
Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone.